Share Name Share Symbol Market Type Share ISIN Share Description
Proteome LSE:PRM London Ordinary Share GB0003104196 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.515p +11.42% 5.025p 4.80p 5.25p 4.76p 4.74p 4.74p 1,344,211.00 16:35:24
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 2.8 -2.9 -1.0 - 14.81

Proteome Sciences PLC Holdings in Company / PDMR Shareholding

04/01/2017 4:36pm

UK Regulatory (RNS & others)


Proteome (LSE:PRM)
Historical Stock Chart

6 Months : From Oct 2016 to Apr 2017

Click Here for more Proteome Charts.

TIDMPRM

RNS Number : 3690T

Proteome Sciences PLC

04 January 2017

Proteome Sciences plc

(the "Company")

Holdings in Company and PDMR Shareholding

Proteome Sciences plc (AIM:PRM) received notification from Vulpes Life Sciences Fund ("Vulpes"), of which Martin Diggle, a non-executive director of the Company, is a director and partner, that today, it purchased 105,590 ordinary shares of 1 pence each ("Ordinary Shares") at 5.5 pence per Ordinary Share (the "Transaction"). Following the Transaction, Vulpes (and Mr Diggle) have a beneficial interest in 53,943,715 Ordinary Shares, representing approximately 18.33% of the current issued share capital of the Company.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 
 1.   Details of the person discharging managerial 
       responsibilities / person closely associated 
---  ----------------------------------------------------------------- 
 a)   Name                             Vulpes Life Sciences Fund 
---  -------------------------------  -------------------------------- 
 2.   Reason for the Notification 
---  ----------------------------------------------------------------- 
 a)   Position/status                  Martin Diggle, non-executive 
                                        director of the Company is 
                                        a director and partner of 
                                        Vulpes Life Sciences Fund 
---  -------------------------------  -------------------------------- 
 b)   Initial notification/Amendment   Initial notification 
---  -------------------------------  -------------------------------- 
 3.   Details of the issuer, emission allowance 
       market participant, auction platform, auctioneer 
       or auction monitor 
---  ----------------------------------------------------------------- 
 a)   Name                             Proteome Sciences plc 
---  -------------------------------  -------------------------------- 
 b)   LEI                              n/a 
---  -------------------------------  -------------------------------- 
 4.   Details of the transaction(s): section to 
       be repeated for (i) each type of instrument; 
       (ii) each type of transaction; (iii) each 
       date; and (iv) each place where transactions 
       have been conducted 
---  ----------------------------------------------------------------- 
 a)   Description of                   Ordinary Shares of 1p each 
       the Financial 
       instrument, type 
       of instrument 
--- 
      Identification                   GB0003104196 
       code 
---  -------------------------------  -------------------------------- 
 b)   Nature of the                    Purchase of Ordinary Shares 
       transaction 
---  -------------------------------  -------------------------------- 
 c)   Price(s) and                      Price(s)   Volume(s) 
       volume(s) 
       04 January 2017                  ---------  ---------- 
                                         5.5p       105,590 
                                        ---------  ---------- 
---  -------------------------------  -------------------------------- 
 d)   Aggregated information: 
        *    Aggregated volume           105,590 Ordinary Shares of 
                                         1 pence each purchased at 
                                         an average price of 5.5 pence 
        *    Price                       per Ordinary Share 
---  -------------------------------  -------------------------------- 
 e)   Date of the transaction          04 January 2017 
---  -------------------------------  -------------------------------- 
 f)   Place of the                     London Stock Exchange, AIM 
       transaction                      Market (XLON) 
---  -------------------------------  -------------------------------- 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHBLGDBSXGBGRS

(END) Dow Jones Newswires

January 04, 2017 11:36 ET (16:36 GMT)

1 Year Proteome Chart

1 Year Proteome Chart

1 Month Proteome Chart

1 Month Proteome Chart
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:31 V:gb D:20170425 16:34:00